International Stem Cell (ISCO) Receivables (2010 - 2026)
International Stem Cell's Receivables came in at $959,000 for Q2 2026, down 12.9% from $1.1 million a year earlier.
Powered by 
Analysis
International Stem Cell (ISCO) Receivables (2010 - 2026) Analysis & Trends
At the end of FY2025, International Stem Cell's Receivables was $723,000, down 31.7% from FY2024.
- Receivables carries a five-year compound annual growth rate of 12.4% (FY2020 to FY2025).
- Going back by year, Receivables was $1.06 million in FY2024 (+84.3%), $574,000 in FY2023 (-23.2%), $747,000 in FY2022 (-11.5%) and $844,000 in FY2021 (+109.4%).
- The five-year range for quarterly Receivables is $427,000 (Q3 2022) to $1.1 million (Q2 2025).
- Year-over-year, Receivables increased in five of the last seven quarters, with growth averaging 23.6%.
- The fastest year-over-year change in Receivables over five years came in Q4 2021 (growth of 109.4%), and the weakest in Q3 2022 (a decline of 36.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 12.49 Bn |
| 10 | International Stem Cell | 2.08 Mn | -1.89 Mn | 1.46 Mn | 959,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 959,000.00 |
| Dec 31, 2025 | 723,000.00 |
| Sep 30, 2025 | 1.02 Mn |
| Jun 30, 2025 | 1.10 Mn |
| Mar 31, 2025 | 851,000.00 |
| Dec 31, 2024 | 1.06 Mn |
| Sep 30, 2024 | 680,000.00 |
| Jun 30, 2024 | 810,000.00 |
| Mar 31, 2024 | 632,000.00 |
| Dec 31, 2023 | 574,000.00 |
| Sep 30, 2023 | 644,000.00 |
| Jun 30, 2023 | 662,000.00 |
| Mar 31, 2023 | 688,000.00 |
| Dec 31, 2022 | 747,000.00 |
| Sep 30, 2022 | 427,000.00 |
| Jun 30, 2022 | 663,000.00 |
| Mar 31, 2022 | 902,000.00 |
| Dec 31, 2021 | 844,000.00 |
| Sep 30, 2021 | 668,000.00 |
| Jun 30, 2021 | 547,000.00 |
API Access
International Stem Cell Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=ISCO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "ISCO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=ISCO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();